Correvio Pharma Corp. Deferred Revenue (Non-Current)
Correvio Pharma Corp. had Deferred Revenue (Non-Current) of $1.23 million as of 2019-12-31, per its 20-F filed 2020-04-30.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2020-04-30
- 2019-12-31: Deferred Revenue, Noncurrent $1.23M.
- 2018-12-31: Deferred Revenue, Noncurrent $1.25M.
- 2018-01-01: Deferred Revenue, Noncurrent $2.80M.
- 2017-12-31: Deferred Revenue, Noncurrent $2.50M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2019-12-31 | $1.23M 20-F · filed 2020-04-30 |
| 2018-12-31 | $1.25M 20-F · filed 2020-04-30 |
| 2018-01-01 | $2.80M 20-F · filed 2020-04-30 |
| 2017-12-31 | $2.50M 20-F · filed 2020-04-30 |
| 2016-12-31 | $2.38M 20-F · filed 2018-04-30 |
| 2015-12-31 | $2.65M 40-F · filed 2017-03-29 |
| 2014-12-31 | $0.00 40-F · filed 2016-03-29 |